Project Grant DP2MH136391

Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $1.4M
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), will provide $123,616.00 to investigate the role of the blood-brain barrier in the trafficking of prenatal liver-derived immune cells into the brain. The research aims to elucidate the cellular and molecular development of the blood-brain barrier and its impact on cellular...
The National Institute of Mental Health (NIMH) awarded a $1,330,586 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The Leland Stanford Junior University. The grant, with a project period from September 1, 2024 to June 30, 2029, will fund research to investigate how changes in cerebrospinal fluid (CSF) potassium levels across brain development impact neural progenitor maintenance, neurogenesis, and brain physiology. The research aims to elucidate the role of...
The National Institute of Mental Health (NIMH) awarded Vanderbilt University a $226,877 Project Grant (CFDA 93.242 - Mental Health Research Grants) to develop the first engineered neurovascular unit (NVU) capable of demonstrating neurovascular coupling (NVC). The project aims to: 1) Conduct studies with smooth muscle cells (SMCs) alone and in co-culture with endothelial cells to demonstrate vasoconstriction and vasodilation in response to vasoactive agents; 2) Produce a population of induced...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $770,502 to The Regents of the University of California, San Francisco (UCSF) from May 1, 2025 to April 30, 2030. The project aims to understand the molecular mechanisms by which collagen IV regulates TGF-beta signaling in a mouse model of cerebral small vessel disease (CSVD), a...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,008,977.00 to the Regents of the University of California, San Francisco to conduct research on the developmental topology of the human cerebral cortex. The key objectives are to understand human brain development and the origins of neurodevelopmental diseases by studying...
The National Institute of Mental Health awarded a three-year Project Grant totaling $3,618,976 to the University of California, Los Angeles under the Mental Health Research Grants program (CFDA 93.242) to develop in situ single-cell multi-omic and morphological profiling methods for mammalian brains. Specifically, the university will work to design photonic-indexing sequencing strategies to spatially barcode tissue with single-cell resolution, integrating techniques such as PI-ATAC-seq and...
This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA Program 93.242 Mental Health Research Grants, will support the development of novel tools to enable researchers to better understand the link between brain structure and function. The $323,978 award to the Child Mind Institute Inc., a non-profit research organization based in New York, will fund three key objectives: 1) extending a brain microstructure reconstruction tool called BrainBuilder to create...
This $444,125.00 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will be used by the University of California, San Francisco (UCSF) to conduct research on the brain maturation-dependent mechanisms underlying hemorrhagic transformation after delayed reperfusion in perinatal and childhood ischemic stroke. The key objectives are to: 1)...
This federal Project Grant award of $692,043 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to investigate the role of presynaptic homeostatic plasticity in mental health disorders such as autism and intellectual disability. The award recipient, The Regents of the University of California, San Francisco (UCSF), will conduct research to elucidate the molecular mechanisms underlying homeostatic plasticity and...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, provides $1,369,101 to the University of California, Los Angeles (UCLA) to conduct research on elucidating the regulation of cell fate specification in human cortical development. The goal is to better understand the etiology of neurodevelopmental disorders. The project will evaluate the signals that drive cortical arealization and laminar...

The National Institute of Mental Health (NIMH) has awarded a $1,388,925 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The Regents of the University of California, San Francisco (UCSF) to conduct research on the role of vascular mural cells in the development of the blood-brain barrier.

The key objectives of this 3-year grant are to: 1) Construct a spatiotemporal atlas of brain mural cells during development using single-cell RNA sequencing and tissue-based detection methods, and 2) Perform lineage tracing with mouse and human cells to interrogate the stage-specific roles of mural cell subtypes in blood-brain barrier development. The research aims to molecularly define the stages and subtypes of mural cells in the developing brain and investigate their contributions as potential stem/progenitor cells for the blood-brain barrier. By advancing the understanding of brain vascular development, this project may inform future therapeutic approaches for genetic and sporadic vascular disorders impacting neurological function.

Generated 7/16/24, 10:16 AM